Back to the fridge
Treatment

Shorter radiation, same results

Comparing Hypofractionated With Conventional Fractionated Radiotherapy After Breast-Conserving Surgery for Early Breast Cancer: A Meta-Analysis of Randomized Controlled Trials

Gu L et al. · Frontiers in Oncology · 2021

The big question

After breast-conserving surgery (removing the tumor but keeping the breast), radiation lowers the chance of cancer coming back. The traditional schedule is 25 daily treatments over 5 weeks. Hypofractionated radiation gives fewer, larger doses, so treatment ends sooner. Does the shorter approach work as well?

What they did

This was a meta-analysis, a study that pools the results of many earlier studies. Researchers combined 14 articles from randomized trials of early-stage breast cancer. In total, 4,869 patients got traditional radiation and 6,072 got the shorter approach. They compared cancer coming back, survival, side effects and how the breast looked afterward.

What they found

There was no significant difference in cancer returning in the breast, survival without relapse, overall survival, or how the breast looked. The shorter approach caused fewer severe side effects, including skin reactions during treatment, hardening of breast tissue, breast shrinkage and pain.

Why it matters

Fewer trips to the clinic can make treatment easier on work, family and daily life. These results suggest people with early breast cancer after breast-conserving surgery may not need to trade convenience for safety.

What it doesn't mean

The trials used different schedules and followed patients for different lengths of time. The results apply to early breast cancer after breast-conserving surgery, not to every situation. The right schedule for you depends on your cancer and your body.

Read the original abstract
Background: The purpose of this meta-analysis was to compare the safety and efficacy between hypofractionated and conventional fractionation radiotherapy in patients with early-stage breast cancer after breast-conserving surgery. Methods: We conducted a comprehensive search of PubMed, Embase, Web of Science, and the Cochrane Library to identify relevant randomized controlled trials (RCTs) published before February 2021. At the same time, the hazard ratio (HR), risk ratio (RR), and 95% confidence interval (CI) were calculated to evaluate local recurrence (LR), relapse-free survival (RFS), overall survival (OS), adverse events, and cosmetic outcomes. Results: A total of 14 articles were included in this meta-analysis. Four thousand eight hundred and sixty-nine patients were randomly assigned to the control group to receive conventional radiotherapy (CFRT); 6,072 patients were randomly assigned to the experimental group and treated with hypofractionated radiotherapy (HFRT). The results showed that there was no statistical difference between HFRT and CFRT in LR (HR = 0.99, 95%CI = 0.97-1.02, p = 0.476), RFS (HR = 0.99, 95%CI = 0.97-1.02, p = 0.485), OS (HR = 1.00, 95%CI = 0.97-1.03, p = 0.879), and cosmetic outcomes (RR = 1.03, 95%CI = 0.95-1.12, p = 0.53). In addition, HFRT showed fewer severe adverse reactions such as acute skin toxicity, induration, breast atrophy, and pain. Conclusion: Our results suggest that there is no statistical difference between HFRT and CFRT in terms of LR, RFS, OS, and cosmetic outcomes. HFRT reduces the risk of developing toxicity reactions compared to CFRT. HFRT may be a better option for patients with early breast cancer after breast-conserving surgery.

Abstract reproduced from Gu L et al., Frontiers in Oncology (2021), under a CC BY 4.0 license, with punctuation lightly adapted. Plain-English summary by Womanhattan.

This summary was written with AI assistance and checked against the original paper. It is for learning, not medical advice. Talk with your care team before changing anything about your health or treatment.